The Sex Paradox

Birds do it. Bees do it. We do it. But not without a physical, biochemical, and genetic price. How did the costly practice of sex become so commonplace?

Written byMegan Scudellari
| 14 min read

Register for free to listen to this article
Listen with Speechify
0:00
14:00
Share

© WORAKIT/ISTOCKPHOTO.COM

Sarah “Sally” Otto was sitting in a lab meeting of evolutionary biologist Marcus Feldman’s group at Stanford University in 1988 when she overheard a graduate student describe sex as “such a big puzzle.” Otto, an undergraduate at the time, didn’t agree. Sexual reproduction—genetic recombination between individuals—“obviously” promotes variation, she thought, allowing species to adapt to changing environments.

WHY SEX?: See full infographic: JPG | PDFOtto’s reaction makes sense, and echoes one of the oldest formal explanations for why sex evolved to be ubiquitous in the animal kingdom. In 1886, German evolutionary biologist August Weismann proposed that sexual reproduction reshuffles genes to create “individual differences” upon which natural selection acts. Additional ideas have emerged since Weismann’s hypothesis: sex rids the genome of deleterious mutations; sex rapidly introduces beneficial mutations; sex helps organisms dodge parasitic infections. Yet these evolutionary justifications for sex have remained hypotheses because there is not enough evidence to suggest that any of them provide enough of a benefit to surmount the exquisitely high costs of sex, which include the time and energy it takes to find a mate, the passage of only half of one’s genes to the next generation, and the breaking apart of favorable gene combinations. (See “Why Sex?”)

“Sexual reproduction permeates biology at every level, and yet it’s not intuitively obvious why it should be that way, because the costs are so high,” says Aneil Agrawal, an evolutionary geneticist at the University of Toronto.

More than 99 percent of multicellular eukaryotes ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies